Correlation Between Amicus Therapeutics and Taysha Gene

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Taysha Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Taysha Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and Taysha Gene Therapies, you can compare the effects of market volatilities on Amicus Therapeutics and Taysha Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Taysha Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Taysha Gene.

Diversification Opportunities for Amicus Therapeutics and Taysha Gene

-0.34

Correlation Coefficient

Amicus Therapeutics  Taysha Gene

Very good diversification

The 3 months correlation between Amicus and Taysha is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Taysha Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taysha Gene Therapies and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Taysha Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taysha Gene Therapies has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Taysha Gene go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Taysha Gene

Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the Taysha Gene. But the stock apears to be less risky and, when comparing its historical volatility, Amicus Therapeutics is 3.16 times less risky than Taysha Gene. The stock trades about -0.04 of its potential returns per unit of risk. The Taysha Gene Therapies is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  199.00  in Taysha Gene Therapies on October 12, 2024 and sell it today you would lose (6.00) from holding Taysha Gene Therapies or give up 3.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Amicus Therapeutics  vs.  Taysha Gene Therapies

Amicus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Taysha Gene Therapies

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Taysha Gene Therapies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Taysha Gene sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Amicus Therapeutics and Taysha Gene

The main advantage of trading using opposite Amicus Therapeutics and Taysha Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Taysha Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taysha Gene will offset losses from the drop in Taysha Gene's long position.

The idea behind Amicus Therapeutics and Taysha Gene Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.